How Cancer Cells Suppress Immune Cells
Author Information
Author(s): A. Uchida, M. Colot, M. Micksche
Primary Institution: Institute for Applied and Experimental Oncology, University of Vienna
Hypothesis
Adherent effusion cells from lung cancer patients suppress natural killer (NK) cell activity.
Conclusion
Adherent effusion cells from cancer patients significantly reduce the motility, binding capacity, and killing ability of NK cells.
Supporting Evidence
- Adherent effusion cells were shown to suppress NK cell activity in multiple assays.
- Functional NK cells lost their motility and binding capacity after contact with adherent effusion cells.
- Significant differences in NK cell activity were observed when comparing assays with and without adherent effusion cells.
Takeaway
Cancer cells can make immune cells less effective at fighting them by stopping them from moving and attacking.
Methodology
Adherent effusion cells were isolated from pleural effusions and their effects on NK cell activity were assessed using various cytotoxicity assays.
Potential Biases
Potential bias due to the selection of patients and the specific cancer type studied.
Limitations
The study primarily focuses on lung cancer patients, which may limit the generalizability of the findings.
Participant Demographics
Patients with lung carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website